Additionally, MWCNT-based nanocomposites increased the infiltration and maturation of DCs, CD8+, CD4+ T cells, macrophages, and NKs in tumours treated with ox-MWCNTs–hypothermia combination therapy [243]. The gene discussed is CD8A; the disease is neoplasm.